AzTrials
AzTrials

Medical DeviceNCT02970903

VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU

A study testing VitalPAD and Traditional tools in people with Medical Device and User-Computer Interface, run by University of British Columbia at 1 site in Canada.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The VitalPAD is a unified, portable and intelligent device that integrates information from multiple patient monitors, mechanical ventilators, infusion pumps and clinical information systems on a mobile platform. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
VitalPAD and Traditional tools
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteCanada
Study dates
Oct 2016to May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Staff pediatric critical care physicians, pediatric critical care fellow physicians or attending physicians, registered pediatric nurses, and respiratory therapists working in the pediatric ICU at BC Children's Hospital

Who cannot join

  • Nursing students and resident physicians are not eligible.
  • For Phase II - Simulation Experiment only: Failure to complete the post-training quiz after two attempts.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Pediatric Anesthesia Research Team, University of British Columbia

    Vancouver, British Columbia, V5Z 4H4

Other trials in Canada

About this study

Official title: VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU; Project Phases 1 (System Development) and 2 (Prototype Evaluation)

The VitalPAD is a unified, portable and intelligent device that integrates information from multiple patient monitors, mechanical ventilators, infusion pumps and clinical information systems on a mobile platform. It will allow nurses, respiratory therapists and physicians to continuously monitor and coordinate care of critically ill patients.

This study will use a participatory design process to guide the design of an integrated mobile device, followed by an evaluation of the proposed device in a simulated ICU setting.

Read the detailed description
  1. Purpose Critically ill patients in the intensive care unit (ICU) need constant monitoring by nurses, respiratory therapists, and physicians. To make decisions and plan therapies, these clinicians must observe and reconcile a vast array of information originating from devices located at the bedsides of multiple patients. Their efforts are hindered by: information being physically limited to the bedside; information overload from the number of devices and separate displays; lack of integration and interaction between devices; displays which fail to present information in a way that is easy to understand; alarm fatigue; lacking historical data or clinical context to support clinical decision making; difficulty locating a team member for consultation or to provide an extra pair of hands This project aims to integrate information from multiple monitoring and therapy devices (multi-parameter monitor, infusion pumps, mechanical ventilator) onto one application, the VitalPAD, hosted on a mobile device (tablet or smartphone). The VitalPAD will process information from multiple bedside monitors in an intelligent decision-support system, and provide an intuitive display of vital signs information, alerts and reminders to ICU healthcare team members. Assigning priority of care and early detection of deterioration of critically ill patients represents an enormous source of preventable morbidity, mortality and cost. Enhanced efficiency in patient monitoring can help reduce the time to detection of critical conditions and improve priority assignment, contributing to enhanced patient safety. The goal of this project is to demonstrate that a mobile application (VitalPAD) can provide dynamic, meaningful, integrated information to intensive care clinicians in real-time. (also see above)
  2. Hypothesis / Aims Part I - Participatory Design. The participatory design process, as proposed by Holtzblatt, for system development is a mixed-method approach. The aim is to develop a prototype that is easy to use, supports decision making, improves awareness of the patient's condition by ICU healthcare team members, and reduces mental workload. Part II - Simulation Experiment. The hypothesis is that in simulated ICU scenarios, critical care physicians, nurses, and respiratory therapists will prioritize the care of critically ill patients more more rapidly and more accurately with the use of VitalPAD than without it. Specifically, using VitalPAD to triage 5 patients will be 30 seconds faster (moderate effect) than performing the same task with the control display. Expected secondary outcomes are a decrease in mental workload as well as an increase in situational awareness.
  3. Justification This research represents a significant opportunity to enhance patient safety in ICUs in Canada and elsewhere by directly advancing the conceptual, theoretical and clinical knowledge required to optimize the use of information in the ICU. It will leverage advances in mobile computing to provide real time support to healthcare providers on the move and reduce cognitive demands. This integrated system aims to enhance performance of the clinicians in real-time, optimize therapeutic interventions, reduce adverse outcomes and ultimately save lives. The aim is to provide healthcare team members with a one-stop solution for their patient monitoring needs, which will improve the way work is done in the ICU and will decrease worker stress, especially for nurses.
  4. Research Design Part I - Participatory design: an inter-professional team of nurses, physicians, designers, engineers, and human factors experts will follow a user-centered design process to refine the system requirements, and obtain feedback during the rapid prototyping phase of prototype development. In Part II - Simulation Experiment: the prototype device will be evaluated in a simulated ICU setting using a triaging task. Answer accuracy and time taken to complete task will be measured. Participants will complete questionnaires (NASA-TLX workload assessment and a PSSUQ usability evaluation).
  5. Statistical Analysis Part I - Participatory design: qualitative methods will be used to analyze and summarize data. Specific themes will be identified and similar themes merged. Specific obstacles to usability, design preferences, and opportunities for information integration will be collated and summarized. In the usability experiment, error rates and task completion times will be used to detail opportunities for additional usability improvements.

Part II - Simulation Experiment:

  • Analysis of Response Time. Mixed linear effect modeling will be used to explore the effects of display, triaging set, and presentation order, and their interactions. Differences between groups (increase or decrease in time taken to triage) will be expressed using the nonparametric Hodges-Lehmann estimator and its 95% confidence limit.
  • Analysis of Answer Accuracy. As a secondary outcome, the number of correct responses for each participant will be recorded. The two proportions will be compared using Fisher's exact test. False positive and false negative detection rates will be compared.
  • Analysis of Workload Scores. The NASA-TLX scores will be analyzed using two approaches: a Friedman's ANOVA, a non-parametric version of the ANOVA, of each of the 6 individual sub-scores to test for individual effects; and an analysis of the weighted composite score using the same statistical test.
  • Analysis of Usability Questionnaire. The PSSUQ results will be tabulated and specific problematic usability issues identified. Friedman's ANOVA will be used to test for individual effects. Feedback provided by the subjects will be screened for improvement of both user interface and decision support system rules.
Being tested
VitalPAD, Traditional tools

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VitalPADDevice

    VitalPAD prototype device

  • Traditional toolsDevice

    Paper based records, screenshots of monitors and therapy devices

Study groups in NCT02970903
Study groupRoleWhat they receive
VitalPADExperimentalUsing VitalPAD prototype device
Receives: Device: VitalPAD
ControlActive comparatorUsing traditional tools (monitors, paper records)
Receives: Device: Traditional tools

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficiency of priority assignment in triaging task

    Efficiency will be measured by the time it takes clinicians to prioritize 5 patients with/without the aid of the VitalPAD

    Measured: Up to 1 hour

Secondary outcomes (1)
  1. Accuracy of priority assignment in triaging task

    Accuracy will be measured by matching of the participants triage priority ranking with the previously defined expert ranking

    Measured: Up to 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2016 (estimated)
  2. Study startOct 2016 (estimated)
  3. Primary completionMay 2019
  4. Study completionMay 2019

Why it stopped: We were unable to secure funding for the triaging experiment. The participatory design process ran its course as intended.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02970903
Sponsor's protocol ID
H16-02361
Status last verified
May 2019
First submitted
21 Oct 2016
Last updated
4 Jun 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VitalPAD and Traditional tools in people with Medical Device and User-Computer Interface, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 4 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficiency of priority assignment in triaging task (time frame: Up to 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in